{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:34Z","timestamp":1791357454986,"version":"4.3.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014235","name":"US WorldMeds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.drugalcdep.2019.107596","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T11:31:39Z","timestamp":1569583899000},"page":"107596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effect of lofexidine on cardiac repolarization during treatment of opioid withdrawal"],"prefix":"10.1016","volume":"205","author":[{"given":"B\u00f6rje","family":"Darp\u00f6","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pirner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Longstreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Ferber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.107596_bib0005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000492616","article-title":"Opioids and cardiac arrhythmia: a literature review","volume":"27","author":"Behzadi","year":"2018","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/hrt.55.3.253","article-title":"Diurnal variation of the QT interval\u2014influence of the autonomic nervous system","volume":"55","author":"Bexton","year":"1986","journal-title":"Br. Heart J."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2125.2008.03327.x","article-title":"Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro","volume":"67","author":"Fanoe","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/ADM.0000000000000474","article-title":"Safety and efficacy of lofexidine for medically managed opioid withdrawal: a randomized controlled clinical trial","volume":"13","author":"Fishman","year":"2018","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0025","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/clpt.2011.273","article-title":"A modeling and simulation approach to characterize methadone QT prolongation using pooled data from five clinical trials in MMT patients","volume":"91","author":"Florian","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0091270007307881","article-title":"Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review","volume":"48","author":"Garnett","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10928-017-9558-5","article-title":"Scientific white paper on concentration-QTc modeling","volume":"45","author":"Garnett","year":"2018","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2017.02.020","article-title":"A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal","volume":"176","author":"Gorodetzky","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0045","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","volume":"5","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.102.038240","article-title":"Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents","volume":"303","author":"Katchman","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0055","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/01.CIR.103.6.850","article-title":"Chronic mu-opioid receptor stimulation in humans decreases muscle sympathetic nerve activity","volume":"103","author":"Kienbaum","year":"2001","journal-title":"Circulation."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ajad.12862","article-title":"Review article: effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment","volume":"28","author":"Kosten","year":"2019","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Pract. Perspect."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012070","article-title":"Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neurons","volume":"2","author":"Mazei-Robison","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/pp.2019.101001","article-title":"Differences in the receptor binding profile of lofexidine compared to clonidine","volume":"10","author":"Raffa","year":"2019","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1592\/phco.29.5.495","article-title":"Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study","volume":"29","author":"Schmittner","year":"2009","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0085","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/bmj.329.7474.1075","article-title":"QT interval increased after single dose of lofexidine","volume":"329","author":"Schmittner","year":"2004","journal-title":"BMJ."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0090","series-title":"Principles of Addiction Medicine","first-page":"589","article-title":"Management of opioid intoxification and withdrawal","author":"Tetrault","year":"2009"},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/jpet.113.209478","article-title":"A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine","volume":"348","author":"Tompkins","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0100","series-title":"Lucemyra [package insert]","author":"US WorldMeds LLC","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107596_bib0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1573403X1201160126122405","article-title":"The impact of opioids on cardiac electrophysiology","volume":"12","author":"Wedam","year":"2016","journal-title":"Curr. Cardiol. Rev."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619303734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619303734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:59:52Z","timestamp":1759827592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619303734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":21,"alternative-id":["S0376871619303734"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107596","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of lofexidine on cardiac repolarization during treatment of opioid withdrawal","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107596"}}